[New, in Austria registered specialty drugs. Normoxin (moxonidine)].
作者信息
Kögler H, Raneburger J
出版信息
Wien Klin Wochenschr. 1993;105(3):94-6.
PMID:8447129
Abstract
摘要
相似文献
1
[New, in Austria registered specialty drugs. Normoxin (moxonidine)].
Wien Klin Wochenschr. 1993;105(3):94-6.
2
[Moxonidine. A new centrally active antihypertensive drug].
Internist (Berl). 1992 Oct;33(10):704-6.
3
Effective antihypertensive therapy: blood pressure control with moxonidine.有效的抗高血压治疗：莫索尼定控制血压
J Cardiovasc Pharmacol. 1996;27 Suppl 3:S38-48.
4
Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.莫索尼定治疗超重和肥胖代谢综合征患者：一项上市后监测研究
J Hum Hypertens. 2004 Sep;18(9):669-75. doi: 10.1038/sj.jhh.1001676.
5
Safety and efficacy of moxonidine in mild to moderate hypertension.莫索尼定治疗轻至中度高血压的安全性和有效性。
J Assoc Physicians India. 2001 Aug;49:829-30.
6
Moxonidine for hypertension.莫索尼定治疗高血压。
Drug Ther Bull. 1997 May;35(5):33-6.
7
Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.新型中枢性抗交感神经降压药莫索尼定的药理学与临床应用
J Hum Hypertens. 1997 Aug;11 Suppl 1:S29-45.
8
Moxonidine well tolerated and effective in the treatment of viscerally obese, non-controlled hypertensive patients.莫索尼定耐受性良好，对内脏型肥胖且血压未得到控制的高血压患者有效。
Cardiovasc J S Afr. 2006 Jul-Aug;17(4):209.
9
Moxonidine: a new antiadrenergic antihypertensive agent.莫索尼定：一种新型抗肾上腺素能降压药。
J Hypertens Suppl. 1999 Aug;17(3):S41-54.
10
Rare psychotropic adverse event of moxonidine.莫索尼定罕见的精神药物不良事件。
Psychiatr Danub. 2009 Dec;21(4):518.
Zotero 插件